Mount Sinai Fertility, Toronto, ON, Canada.
Department of Molecular Medicine and Surgery, Karolinska Institutet and Clinical Genetics, Karolinska University Laboratory, Karolinska University Hospital, Stockholm, Sweden.
Acta Obstet Gynecol Scand. 2020 Jun;99(6):707-715. doi: 10.1111/aogs.13821. Epub 2020 Mar 2.
Preimplantation genetic testing (PGT) is growing in importance and volume internationally. International societies such as the European Society for Human Reproduction and Embryology compile international results and these data are published in scientific journals. We present the first compilation of practices, quality measuress and outcome data from Nordic clinics performing PGT.
We conducted a structured online survey of PGT practices in the Nordic countries to compare clinical and laboratory techniques, outcomes and quality measures applied in Nordic clinics. The survey was designed by the authors and answered by the authors and members of the study group. The outcome data represents results from 2018. Results and details were clarified through iteration with responding clinics while maintaining anonymity. Response rate in the study was 80%, with 8 of 10 clinics performing PGT responding.
Most of the PGT cycles in the Nordic countries are funded through the public healthcare system with University Hospitals performing the majority of treatments, 716/848, or 84.4%, of oocyte retrievals in this dataset. The genetic analyses are in five cases performed by the affiliated local genetic laboratory, and the remaining three consult with large international private enterprise laboratories. Genetic counseling is widely used. Results in the Nordic clinics compare well with international data. Systematic quality control procedures are in place and the larger clinics and laboratories utilize ISO certification or accreditation in the quality management. Automatic witnessing with detailed electronic documentation of laboratory processes is not utilized in the responding clinics, although a majority uses manual witnessing procedures in the laboratory. The outcome after PGT in terms of clinical pregnancy per transfer is around 40% per embryo transfer and compares well with international data.
Preimplantation genetic testing is organized in rather few clinics in the Nordic countries and most of them use local laboratories for genetic analyses of the biopsies. Laboratory procedures are largely in accordance with international guidelines and the outcome after PGT in terms of clinical pregnancy per transfer is comparable to results in international reports.
胚胎植入前遗传学检测(PGT)在国际上的重要性和数量都在不断增加。欧洲人类生殖与胚胎学会等国际学会对国际结果进行了汇编,这些数据发表在科学期刊上。我们首次汇编了北欧进行 PGT 的诊所的实践、质量措施和结果数据。
我们对北欧国家的 PGT 实践进行了结构化的在线调查,以比较北欧诊所应用的临床和实验室技术、结果和质量措施。该调查由作者设计,并由作者和研究小组的成员回答。结果数据代表了 2018 年的结果。通过与回复诊所的反复迭代,在保持匿名的同时澄清了结果和细节。该研究的回复率为 80%,10 家进行 PGT 的诊所中有 8 家做出了回复。
北欧国家的大多数 PGT 周期都通过公共医疗保健系统资助,大学医院进行了大多数治疗,在本数据集中,716/848 个卵母细胞采集是由大学医院进行的,占 84.4%。遗传分析在五个案例中由附属当地遗传实验室进行,其余三个则咨询大型国际私营企业实验室。遗传咨询被广泛应用。北欧诊所的结果与国际数据相比非常好。系统的质量控制程序已经到位,较大的诊所和实验室利用 ISO 认证或认证进行质量管理。虽然大多数实验室在实验室过程中使用手动见证程序,但回复诊所没有利用自动见证程序,即详细的电子实验室过程文档。PGT 后的临床妊娠每转移胚胎的结果约为 40%,与国际数据相当。
胚胎植入前遗传学检测在北欧国家的诊所数量相对较少,它们中的大多数使用当地实验室对活检进行遗传分析。实验室程序在很大程度上符合国际指南,PGT 后每转移胚胎的临床妊娠结果与国际报告中的结果相当。